Cargando…

Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”

Despite the success of highly active antiretroviral therapy (HAART), integrated HIV-1 proviral DNA cannot be eradicated from an infected individual. HAART is not able to eliminate latently infected cells that remain invisible to the immune system. Viral sanctuaries in specific tissues and immune-pri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acchioni, Chiara, Palermo, Enrico, Sandini, Silvia, Acchioni, Marta, Hiscott, John, Sgarbanti, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622007/ https://www.ncbi.nlm.nih.gov/pubmed/34832672 http://dx.doi.org/10.3390/pathogens10111517

Ejemplares similares

HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation
por: Remoli, Anna Lisa, et al.
Publicado: (2016)

IκB kinase-ε-mediated phosphorylation triggers IRF-1 degradation in breast cancer cells
por: Remoli, Anna Lisa, et al.
Publicado: (2020)

Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy
por: Marsili, Giulia, et al.
Publicado: (2023)

Type I Interferons in COVID-19 Pathogenesis
por: Palermo, Enrico, et al.
Publicado: (2021)

New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
por: Mariotti, Sabrina, et al.
Publicado: (2023)

The function of Shoc2: A scaffold and beyond
por: Jang, Eun Ryoung, et al.
Publicado: (2016)

Shoc2/Sur8 Protein Regulates Neurite Outgrowth
por: Leon, Gonzalo, et al.
Publicado: (2014)

Functional Integration of the Conserved Domains of Shoc2 Scaffold
por: Jeoung, Myoungkun, et al.
Publicado: (2013)

Structural basis for SHOC2 modulation of RAS signalling
por: Liau, Nicholas P. D., et al.
Publicado: (2022)

MTP Arthrodesis: Outcomes of Crossroads Dynaforce and Stryker Locking Plate
por: Andrews, Nicholas A., et al.
Publicado: (2022)

Expanding the molecular spectrum of pathogenic SHOC2 variants underlying Mazzanti syndrome
por: Motta, Marialetizia, et al.
Publicado: (2022)

Data set for transcriptional response to depletion of the Shoc2 scaffolding protein
por: Rouchka, Eric C., et al.
Publicado: (2016)

Structure of the MRAS–SHOC2–PP1C phosphatase complex
por: Hauseman, Zachary J., et al.
Publicado: (2022)

SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics
por: Boned del Río, Isabel, et al.
Publicado: (2019)

Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling
por: Kaduwal, Saluja, et al.
Publicado: (2015)

HIV-1 Nef: at the crossroads
por: Foster, John L, et al.
Publicado: (2008)

AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS)
por: Bellamy, Richard, et al.
Publicado: (2004)

Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency
por: Mariotti, Sabrina, et al.
Publicado: (2021)

Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
por: Xiao-pei, Huang, et al.
Publicado: (2018)

Correction: Systematic identification of celastrol-binding proteins reveals that Shoc2 is inhibited by celastrol
Publicado: (2021)

Shoc2 recognizes bacterial flagellin and mediates antibacterial Erk/Stat signaling in an invertebrate
por: Zhao, Bao-Rui, et al.
Publicado: (2022)

SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
por: Geng, Wenwen, et al.
Publicado: (2023)

The Coronavirus pandemic – 2022: Viruses, variants & vaccines
por: Alexandridi, Magdalini, et al.
Publicado: (2022)

HIV-1 Latency: An Update of Molecular Mechanisms and Therapeutic Strategies
por: Battistini, Angela, et al.
Publicado: (2014)

Ras and Calcium Signaling Pathways Converge at Raf1 via the Shoc2 Scaffold Protein
por: Yoshiki, Sayaka, et al.
Publicado: (2010)

Clinical Heterogeneity in two patients with Noonan-like Syndrome associated with the same SHOC2 mutation
por: Capalbo, Donatella, et al.
Publicado: (2012)

HIV Treatment-as-Prevention Research at a Crossroads
por: Bärnighausen, Till, et al.
Publicado: (2014)

HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads
por: Borgmann, Kathleen, et al.
Publicado: (2015)

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
por: Gavegnano, Christina, et al.
Publicado: (2019)

Shoc2 Is Targeted to Late Endosomes and Required for Erk1/2 Activation in EGF-Stimulated Cells
por: Galperin, Emilia, et al.
Publicado: (2012)

SPO16 binds SHOC1 to promote homologous recombination and crossing-over in meiotic prophase I
por: Zhang, Qianting, et al.
Publicado: (2019)

SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers
por: Jones, Greg G., et al.
Publicado: (2019)

SHOC2 is associated with the survival of breast cancer cells and has prognostic value for patients with breast cancer
por: Geng, Wenwen, et al.
Publicado: (2020)

Bi-allelic SHOC1 loss-of-function mutations cause meiotic arrest and non-obstructive azoospermia
por: Yao, Chencheng, et al.
Publicado: (2021)

Cutaneous T-cell lymphoma in SHOC2 mutation-associated Noonan-like syndrome with loose anagen hair
por: Avery, Alexandria, et al.
Publicado: (2022)

Crossroad
por: Paz-Pacheco, Elizabeth
Publicado: (2022)

Management of complex wrist fractures with volar and dorsal locked (double-locked) K-lock
por: du Plessis, Prieur, et al.
Publicado: (2023)

PI3K at the crossroads of tumor angiogenesis signaling pathways
por: Soler, Adriana, et al.
Publicado: (2015)

Mutation in SHOC2 promotes aberrant protein N-myristoylation and underlies Noonan-like syndrome with loose anagen hair
por: Cordeddu, Viviana, et al.
Publicado: (2009)

Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11
por: Chen, Jin-Lan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jsbi88029vk0qk16nenq6361jq